CASI Pharmaceuticals, Inc (DE) Quarterly Common Stock, Shares, Issued from Q4 2010 to Q4 2022

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
CASI Pharmaceuticals, Inc (DE) quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q4 2022.
  • CASI Pharmaceuticals, Inc (DE) Common Stock, Shares, Issued for the quarter ending December 31, 2022 was 13.7M shares, a 1.82% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 13.7M -254K -1.82% Dec 31, 2022 20-F 2023-04-26
Q3 2022 13.7M -126M -90.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 13.7M -126M -90.2% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 137M -2.54M -1.82% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 14M -110M -88.7% Dec 31, 2021 20-F 2023-04-26
Q3 2021 140M +15.9M +12.8% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 140M +38.9M +38.5% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 140M +38.9M +38.5% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 124M +26.2M +26.7% Dec 31, 2020 10-K 2022-03-28
Q3 2020 124M +27.6M +28.6% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 101M +5.21M +5.44% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 101M +5.2M +5.43% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 97.9M +2.48M +2.61% Dec 31, 2019 10-K 2021-03-30
Q3 2019 96.4M +2.94M +3.14% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 95.8M +9.21M +10.6% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 95.8M +16.1M +20.2% Mar 31, 2019 10-Q 2019-05-15
Q4 2018 95.4M +25.5M +36.4% Dec 31, 2018 10-K 2020-03-16
Q3 2018 93.5M +33.2M +55.1% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 86.6M +26.3M +43.7% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 79.7M +19.4M +32.3% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 69.9M +9.63M +16% Dec 31, 2017 10-K 2019-03-29
Q3 2017 60.3M +10.7M +21.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 60.3M +12.7M +26.7% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 60.3M +17.6M +41.3% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 60.3M +27.8M +85.3% Dec 31, 2016 10-K 2018-03-29
Q3 2016 49.5M +17M +52.3% Sep 30, 2016 10-Q 2016-11-14
Q2 2016 47.6M +15M +46.3% Jun 30, 2016 10-Q 2016-08-15
Q1 2016 42.7M +10.1M +31.2% Mar 31, 2016 10-Q 2016-05-13
Q4 2015 32.5M 0 0% Dec 31, 2015 10-K 2017-03-31
Q3 2015 32.5M 0 0% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 32.5M +5.41M +19.9% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 32.5M +5.41M +19.9% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 32.5M +5.41M +19.9% Dec 31, 2014 10-K 2016-03-28
Q3 2014 32.5M +5.41M +19.9% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 27.1M +17.4K +0.06% Jun 30, 2014 10-Q 2014-08-14
Q1 2014 27.1M +17.4K +0.06% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 27.1M +4.54M +20.1% Dec 31, 2013 10-K 2015-03-27
Q3 2013 27.1M +4.54M +20.1% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 27.1M +4.52M +20% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 27.1M +14.9M +121% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 22.6M +10.3M +84.5% Dec 31, 2012 10-K 2014-03-21
Q3 2012 22.6M +10.3M +84.5% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 22.6M +10.9M +94.1% Jun 30, 2012 10-Q 2012-08-14
Q1 2012 12.2M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 12.2M +720K +6.25% Dec 31, 2011 10-K 2013-03-21
Q3 2011 12.2M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 11.6M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 11.5M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.